Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China
· Delayed Price · Currency is CNY 8.33
+0.04 (0.48%)
Apr 30, 2026, 1:55 PM CST
SHE:002566 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 33.28 | 29 | 52.09 | 94.73 | 83.1 | 96.02 | Upgrade
|
| Depreciation & Amortization | 42.7 | 42.7 | 47.08 | 48.93 | 44.27 | 43.09 | Upgrade
|
| Other Amortization | 0.68 | 0.68 | 0.63 | 1.53 | 0.92 | 1.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.4 | -0.4 | -0.29 | -0.78 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.3 | 0.3 | 0.27 | 0.24 | 0.27 | 0.28 | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.53 | -9.53 | -11.98 | -4.02 | -2.62 | -0.25 | Upgrade
|
| Provision & Write-off of Bad Debts | 2.13 | 2.13 | -0.23 | - | 1.27 | -0.46 | Upgrade
|
| Other Operating Activities | 20.88 | 15.6 | 14.26 | 10.88 | 19.99 | 22.41 | Upgrade
|
| Change in Accounts Receivable | -29.65 | -29.65 | 5.21 | 75.22 | -17.02 | -31.92 | Upgrade
|
| Change in Inventory | 43.03 | 43.03 | -11.33 | -12.65 | -4.99 | 17.85 | Upgrade
|
| Change in Accounts Payable | 8.01 | 8.01 | -37.26 | -7.09 | 18.54 | 64.21 | Upgrade
|
| Operating Cash Flow | 108.3 | 98.74 | 58.94 | 209.13 | 145.86 | 215.1 | Upgrade
|
| Operating Cash Flow Growth | 183.45% | 67.51% | -71.81% | 43.38% | -32.19% | 5.69% | Upgrade
|
| Capital Expenditures | -7.41 | -13.64 | -15.94 | -35.77 | -41.36 | -107.07 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.12 | 0.28 | 0.45 | 0.74 | - | 0 | Upgrade
|
| Investment in Securities | 68.26 | -51.76 | -365 | -40 | 40 | -100 | Upgrade
|
| Other Investing Activities | 14.71 | 11.71 | 5.29 | 1.64 | 3.13 | - | Upgrade
|
| Investing Cash Flow | 75.68 | -53.42 | -375.21 | -73.39 | 1.77 | -207.06 | Upgrade
|
| Short-Term Debt Issued | - | 20 | - | - | 430 | 397.45 | Upgrade
|
| Long-Term Debt Issued | - | 333 | 600 | 520 | - | - | Upgrade
|
| Total Debt Issued | 348 | 353 | 600 | 520 | 430 | 397.45 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -400 | -415 | Upgrade
|
| Long-Term Debt Repaid | - | -360.64 | -638.35 | -484.84 | -3.06 | -5.75 | Upgrade
|
| Total Debt Repaid | -355.64 | -360.64 | -638.35 | -484.84 | -403.06 | -420.75 | Upgrade
|
| Net Debt Issued (Repaid) | -7.64 | -7.64 | -38.35 | 35.16 | 26.94 | -23.3 | Upgrade
|
| Common Dividends Paid | -45.02 | -45.61 | -61.64 | -29.86 | - | -23.32 | Upgrade
|
| Other Financing Activities | -7.31 | - | - | 3.43 | -50.99 | -28.72 | Upgrade
|
| Financing Cash Flow | -59.96 | -53.25 | -99.99 | 8.73 | -24.06 | -75.34 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | 0 | -0 | - | - | - | Upgrade
|
| Net Cash Flow | 124.02 | -7.93 | -416.25 | 144.47 | 123.57 | -67.3 | Upgrade
|
| Free Cash Flow | 100.89 | 85.1 | 43 | 173.36 | 104.49 | 108.04 | Upgrade
|
| Free Cash Flow Growth | 264.38% | 97.89% | -75.19% | 65.91% | -3.28% | -15.32% | Upgrade
|
| Free Cash Flow Margin | 15.29% | 13.29% | 6.43% | 20.31% | 12.59% | 12.31% | Upgrade
|
| Free Cash Flow Per Share | 0.30 | 0.26 | 0.13 | 0.52 | 0.32 | 0.33 | Upgrade
|
| Cash Income Tax Paid | 90.04 | 89.77 | 96.65 | 113.44 | 100.26 | 98.63 | Upgrade
|
| Levered Free Cash Flow | 87.67 | 54.51 | 9.65 | 94.72 | 77.27 | 5.5 | Upgrade
|
| Unlevered Free Cash Flow | 95.56 | 62.4 | 18.3 | 103.26 | 86.04 | 13.85 | Upgrade
|
| Change in Working Capital | 18.26 | 18.26 | -42.87 | 57.63 | -1.34 | 52.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.